蒙药
Search documents
机制创新破堵点 营商提质激活力
Xin Lang Cai Jing· 2026-01-11 18:13
Group 1: Project Approval and Mechanism Innovation - The time for obtaining land pre-approval and site selection for wind power projects has been reduced from 5 working days to 2, significantly benefiting project initiation [1] - A cross-departmental special working group has been established to facilitate "one-stop" processing of preliminary procedures for major projects, enhancing efficiency [1] - Since the implementation of the new mechanism, 128 new projects planned for 2026 have been assessed, leading to expedited approvals and addressing initial project implementation challenges [1] Group 2: Financial Support and Collaboration - A recent meeting in Zhalaihe Banner brought together nearly 20 financial institutions and over 40 enterprises, resulting in 10 financial institutions signing agreements with 11 enterprises to support the real economy [2] - The timely financial support has been crucial for local businesses, such as Jinbaisui Grain and Oil Trade Co., which highlighted the importance of new credit for grain procurement and business development [2] - In Tuquan County, proactive visits by bank staff to small and micro enterprises have facilitated quick loan approvals, addressing financing challenges effectively [2] Group 3: Legal Services and Risk Management - The establishment of a legal service area in the government service center has provided continuous legal assistance, with over 5,700 cases handled and legal consultations accounting for over 15% [3] - The legal service model focuses on proactive risk management, helping enterprises identify and mitigate potential risks in areas such as intellectual property and contract management [3] - A collaborative legal health check for specialized small and medium enterprises has been conducted, resulting in personalized reports and corrective action plans to enhance compliance capabilities [3] Group 4: Credit Repair Mechanism - The "Qibaixing" cross-regional credit repair collaboration mechanism has been implemented, allowing enterprises to submit materials online without needing to travel to the location of penalties [4] - This mechanism has streamlined the credit repair process, enabling efficient resolution of previously cumbersome tasks [4] - Since the beginning of the year, 14 enterprises have benefited from this cross-regional credit repair initiative, enhancing market confidence and vitality [5] Group 5: Continuous Improvement of Business Environment - The ongoing optimization of the business environment is emphasized, with a focus on institutional innovation and precise services to enhance service quality and development efficiency [5] - The efforts aim to create a supportive environment for enterprises to thrive and grow in the region [5]
奥特奇蒙药董事长向公伟: 全产业链布局 推动蒙医药理论标准化
Zhong Guo Zheng Quan Bao· 2025-05-05 20:40
Core Insights - The company has achieved a 40-fold growth in sales over the past decade, establishing itself as a leader in the Mongolian medicine industry [1][3] - The company employs a "five-in-one" full industry chain model, focusing on direct sourcing of authentic medicinal materials to ensure drug quality [1][3] - Future plans include deepening the full industry chain development and innovation, aiming for exponential growth in the Mongolian medicine market through the creation of multiple flagship products [1][2] Company Development - The company has developed a comprehensive system integrating medicinal material cultivation, research and development, production, sales, and modern pharmaceutical logistics [2] - It has established a collaborative innovation system that combines traditional Mongolian medicine with modern medical practices, leveraging academic and research partnerships [2][4] - The company has successfully created a cluster of proprietary insurance products, including 28 varieties covered by national insurance and 14 exclusive products [2][3] Research and Innovation - The company is focused on new drug development and the secondary development of traditional Mongolian medicine, with a strategic plan spanning three five-year phases [4] - It is currently advancing a first-class new drug for treating cerebrovascular diseases, which is in the second phase of research and is expected to be launched in 5-7 years [4] - The company is also working on modernizing Mongolian medicine through evidence-based research and establishing a standardized theoretical framework that is accessible to both Chinese and Western medical experts [4][5] Technological Advancements - The company is leveraging DNA genomics and AI technology to enhance the efficiency of traditional medicine research, potentially reducing the time required to discover effective components from decades to days [5][6] - The company aims to be a pioneer in the transformative changes in traditional medicine research brought about by advancements in AI technology [6]